Avinger-healthcare_professionals-hero-mobile Avinger-healthcare_professionals-hero-tablet
healthcare_professionals

Your decisions today help build the future

banner-img07

Healthcare Professionals

Lumivascular technology is radically changing the way vascular disease is treated. Through the CONNECT II and VISION trial, we were able to receive FDA clearance on both our CTO crossing catheter (Ocelot) and atherectomy catheter (Pantheris). Being able to see inside the artery with Optical Coherence Tomography (OCT) while performing the procedure is a real game changer. It allows the operator to make informed decisions for long term results while leaving normal arterial layers behind.

See Case Studies

Clinical trials prove safety.

Gathering information through seeing inside the artery while performing the procedure may allow for better long term outcomes when you don’t disturb healthy layers of the artery. The data below shows the importance of visualization inside the artery.

vision ide 6 month
lumivascular ATHERECTOMY

130 PATIENTS | 20 SITES | 164 LESIONS

LUMINAL GAIN | 72%

  • 79%

    PRE-STENOSIS

  • 30%

    PANTHERIS STANDALONE

  • 22%

    POST-PANTHERIS +/- ADJUNCTIVE THERAPY

adventitia analysis

Adventitia

EFFICACY

Dissections

Safety

Perforations

follow-up comparative data
lumivascular ATHERECTOMY

freedom form tlr

SOURCE: VISION IDE (6 MONTH) & VISION INTERIM DATA
KM CURVE* (12, 24 MONTH)

  • 92%

    6 MONTH***

  • 86%

    12 MONTH

  • 82%

    24 MONTH

  • Amputations

FREEDOM FROM TLR & PATENCY **

SOURCE: EUROPEAN CASE SERIES (GRAZ, AUSTRIA)

  • 88%

    FREEDOM FROM TLR (12 MONTH****)

  • 86%

    PATENCY (12 MONTH****)

* VISION Interim Data Included 55 patients on January 18, 2017

** Patency is defined as PSVR < 2.4

*** VISION IDE 6 Month data included the primary cohort only

**** European Case Series N=29 patients

CONNECT II DATA
LUMIVASCTULAR CTO CROSSING

100 PATIENTS | 14 SITES | 100 LESIONS

Efficacy
Safety

LUMINAL CROSSING

  • 93%

    93% = TRUE LUMEN

  • 7%

    7% - SUBINTIMAL

banner-img06

Case Studies

View cases performed by your peers and colleagues in lesions below the knee, above the knee, CTOs, and more. These cases help show how Ocelot and Pantheris are changing the way operators see and perform procedures.

view case studies

Events with Avinger

Visit Avinger at the following upcoming events to learn more on how Lumivascular is radically changing the way vascular disease is treated.

IMAGINE

Scottsdale, AZ
  • November 17-18, 2016
  • Hosted by John B. Simpson PhD MD

LINC

Leipzig, Germany
  • January 24-27, 2017
  • Booth 7C Hall 2
  • AGENDA
  • ARNE SCHWINDT MD
  • IAN CAWICH MD
  • ARJUN DESAI MD
  • GLEN SCHWARTZBERG MD
  • JAAFER GOLZAR MD
  • SEAN JANZER MD
  • JON GEORGE MD
  • MARIANNE BRODMANN MD
  • JIHAD MUSTAPHA MD
  • TOM DAVIS MD
Past events